C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $666 | -53.1% | 357,988 | -30.7% | 0.00% | -50.0% |
Q2 2023 | $1,421 | +38.8% | 516,898 | +58.5% | 0.00% | +100.0% |
Q1 2023 | $1,024 | +433.3% | 326,080 | +903.3% | 0.00% | – |
Q4 2022 | $192 | -100.0% | 32,500 | -48.2% | 0.00% | -100.0% |
Q3 2022 | $551,000 | +533.3% | 62,800 | +446.1% | 0.00% | – |
Q2 2022 | $87,000 | -91.4% | 11,500 | -63.3% | 0.00% | -100.0% |
Q4 2021 | $1,008,000 | – | 31,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |